{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:34:02Z","timestamp":1760056442174,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.ncl.2021.08.010","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T10:50:43Z","timestamp":1637146243000},"page":"157-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recognition and Management of Neuromuscular Emergencies"],"prefix":"10.1016","volume":"40","author":[{"given":"Arun S.","family":"Varadhachary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ncl.2021.08.010_bib1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1212\/WNL.0b013e3182315249","article-title":"A\u00a0randomized trial of hypothesis-driven vs screening neurologic examination","volume":"77","author":"Kamel","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ana.410280114","article-title":"The accuracy of bedside neurological diagnoses","volume":"28","author":"Chimowitz","year":"1990","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.010_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mus.24606","article-title":"Diagnostic evaluation of rhabdomyolysis","volume":"51","author":"Nance","year":"2015","journal-title":"Muscle Nerve"},{"author":"Pestronk","key":"10.1016\/j.ncl.2021.08.010_bib4"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.010_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00008480-200404000-00017","article-title":"Drug-induced rhabdomyolysis","volume":"16","author":"Coco","year":"2004","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib6","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s13311-018-00684-2","article-title":"Myopathies related to glycogen metabolism disorders","volume":"15","author":"Tarnopolsky","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"9","key":"10.1016\/j.ncl.2021.08.010_bib7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.010_bib9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.010_bib10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/rheumatology\/kex226","article-title":"2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects","volume":"56","author":"Rider","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0889-857X(21)00074-0","article-title":"Relationship of cancer to inflammatory muscle diseases. Dermatomyositis, polymyositis, and inclusion body myositis","volume":"20","author":"Callen","year":"1994","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib12","doi-asserted-by":"crossref","first-page":"e03707","DOI":"10.1016\/j.heliyon.2020.e03707","article-title":"Value of (18)F-FDG PET\/CT in the detection of occult malignancy in patients with dermatomyositis","volume":"6","author":"Li","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.ncl.2021.08.010_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3389\/fneur.2018.00839","article-title":"Muscle biopsy and electromyography correlation","volume":"9","author":"Naddaf","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.ncl.2021.08.010_bib14","series-title":"Electromyography and neuromuscular disorders: clinical-electrophysiologic correlations","first-page":"xvii","author":"Preston","year":"2013"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1468-1331.2009.02765.x","article-title":"Open muscle biopsy in suspected myopathy: diagnostic yield and clinical utility","volume":"17","author":"Lai","year":"2010","journal-title":"Eur J Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.010_bib16","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnen\/nlaa046","article-title":"What every neuropathologist needs to know: the muscle biopsy","volume":"79","author":"Nix","year":"2020","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.010_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nmd.2018.02.006","article-title":"Muscle biopsy technical safety and quality using a self-contained, vacuum-assisted biopsy technique","volume":"28","author":"Gallo","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.010_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mus.24307","article-title":"Combining MRI and muscle biopsy improves diagnostic accuracy in subacute-onset idiopathic inflammatory myopathy","volume":"51","author":"Van De Vlekkert","year":"2015","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.010_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1093\/hmg\/ddy364","article-title":"MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD","volume":"28","author":"Wang","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0037-1604007","article-title":"Advanced MRI techniques for muscle imaging","volume":"21","author":"Kalia","year":"2017","journal-title":"Semin Musculoskelet Radiol"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMc1506827","article-title":"Inflammatory muscle diseases","volume":"373","author":"Dalakas","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.010_bib22","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"27","key":"10.1016\/j.ncl.2021.08.010_bib23","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A\u00a0controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib24","doi-asserted-by":"crossref","first-page":"e23677","DOI":"10.1097\/MD.0000000000023677","article-title":"Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (\u201cProDERM Study\u201d)","volume":"100","author":"Aggarwal","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.010_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13063-017-2016-2","article-title":"Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial","volume":"18","author":"Saunders","year":"2017","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1212\/01.CON.0000411569.72203.9d","article-title":"Immune-mediated neuropathies","volume":"18","author":"So","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"issue":"11","key":"10.1016\/j.ncl.2021.08.010_bib28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41582-019-0250-9","article-title":"Diagnosis and management of Guillain-Barre syndrome in ten steps","volume":"15","author":"Leonhard","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.010_bib29","first-page":"276","article-title":"Immune checkpoint inhibitor-related guillain-barre syndrome: a case series and review of the literature","volume":"44","author":"Janssen","year":"2021","journal-title":"J\u00a0Immunother"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/14740338.2020.1738382","article-title":"Neurologic complications of immune checkpoint inhibitors","volume":"19","author":"Haugh","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"8","key":"10.1016\/j.ncl.2021.08.010_bib31","doi-asserted-by":"crossref","first-page":"e0007622","DOI":"10.1371\/journal.pntd.0007622","article-title":"Incidence of Guillain-Barre Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: a systematic review and meta-analysis","volume":"13","author":"Capasso","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.010_bib32","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(07)70130-8","article-title":"A\u00a0clinical prognostic scoring system for Guillain-Barre syndrome","volume":"6","author":"van Koningsveld","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2021.08.010_bib33","article-title":"Intravenous immunoglobulin for Guillain-Barre syndrome","volume":"9","author":"Hughes","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ncl.2021.08.010_bib34","article-title":"Plasma exchange for Guillain-Barre syndrome","volume":"2","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.010_bib35","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/jnnp-2019-321496","article-title":"Original research: second IVIg course in Guillain-Barre syndrome with poor prognosis: the non-randomised ISID study","volume":"91","author":"Verboon","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.010_bib36","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1474-4422(18)30114-5","article-title":"Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial","volume":"17","author":"Misawa","year":"2018","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2021.08.010_bib37","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/rheumatology\/kez311","article-title":"The therapeutic efficacy of intravenous immunoglobulin in anti-neutrophilic cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"59","author":"Shimizu","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.010_bib38","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.010_bib39","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ncl.2021.08.010_bib40","first-page":"1446","article-title":"ANCA-associated vasculitis: an update","volume":"10","author":"Almaani","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"18","key":"10.1016\/j.ncl.2021.08.010_bib41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1212\/WNL.0b013e3181a41211","article-title":"Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals","volume":"72","author":"Alshekhlee","year":"2009","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.010_bib42","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2021.08.010_bib43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.25597","article-title":"Rituximab treatment of myasthenia gravis: a systematic review","volume":"56","author":"Tandan","year":"2017","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.ncl.2021.08.010_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1060028019864574","article-title":"Amifampridine for the management of lambert-eaton myasthenic syndrome: a new take on an old drug","volume":"54","author":"Yoon","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.ncl.2021.08.010_bib46","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/ajrccm\/144.4.814","article-title":"Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome","volume":"144","author":"Chevrolet","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"10.1016\/j.ncl.2021.08.010_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archneur.58.6.893","article-title":"Anticipating mechanical ventilation in Guillain-Barre syndrome","volume":"58","author":"Lawn","year":"2001","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.010_bib48","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1385\/NCC:5:3:230","article-title":"Factors predicting extubation success in patients with Guillain-Barre syndrome","volume":"5","author":"Nguyen","year":"2006","journal-title":"Neurocrit Care"},{"issue":"3","key":"10.1016\/j.ncl.2021.08.010_bib49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s12028-020-00965-9","article-title":"Effect of early tracheostomy on mortality of mechanically ventilated patients with guillain-barre syndrome: a nationwide observational study","volume":"33","author":"Yonezawa","year":"2020","journal-title":"Neurocrit Care"},{"issue":"12","key":"10.1016\/j.ncl.2021.08.010_bib50","first-page":"1403","article-title":"Mechanical ventilation in patients with Guillain-Barre syndrome","volume":"51","author":"Ali","year":"2006","journal-title":"Respir Care"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2021.08.010_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2012.02.026","article-title":"Residual disability 10 years after falling ill in Guillain-Barre syndrome: a prospective follow-up study","volume":"317","author":"Forsberg","year":"2012","journal-title":"J\u00a0Neurol Sci"},{"issue":"10","key":"10.1016\/j.ncl.2021.08.010_bib52","first-page":"1318","article-title":"Determination of pain and response to methylprednisolone in Guillain-Barre syndrome","volume":"254","author":"Ruts","year":"2007","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2021.08.010_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/1076029620907954","article-title":"The incidence and characteristics of venous thromboembolism in neurocritical care patients: a prospective observational study","volume":"26","author":"Zhang","year":"2020","journal-title":"Clin Appl Thromb Hemost"},{"issue":"19","key":"10.1016\/j.ncl.2021.08.010_bib54","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861921000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:18:47Z","timestamp":1760005127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861921000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0733861921000827"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2021.08.010","relation":{},"ISSN":["0733-8619"],"issn-type":[{"type":"print","value":"0733-8619"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognition and Management of Neuromuscular Emergencies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2021.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}